Risperdal is indicated for the treatment of schizophrenia and manifestations of psychotic disorders. The antipsychotic effectiveness of Rispond has been established in short-term (6 to 8 weeks) controlled studies in patients with schizophrenia.
Risperdal is indicated for the treatment of psychotic manifestations of dementia. Conduct and other disruptive disorders. Treatment of behavioral disorders expressed in impulse control disorders or self-alienation, aggressive or behavior disorders requiring treatment with reduced or substandard intelligence.
Risperdal is indicated for the treatment of mania in bipolar disorder. These episodes are characterized by symptoms such as increased expansive or irritable mood, inflated self-esteem, decreased need for sleep stress, speech, distracting thoughts, distractible thoughts or poor judgment including frustration or aggressive behavior.
Active ingredient: risperidone
1 Mg, 2 Mg, 3 Mg, 4 Mg